Niagen Bioscience, Inc. (NAGE)
4.86
-0.08
(-1.72%)
USD |
NASDAQ |
Feb 20, 16:00
4.86
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience EPS Diluted (Quarterly) : 0.0528 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Nephros, Inc. | 0.0305 |
| Harrow, Inc. | 0.0262 |
| Astrana Health, Inc. | 0.0075 |
| Clover Health Investments Corp. | -0.0475 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.578M |
| Revenue (Quarterly) | 33.99M |
| Total Expenses (Quarterly) | 29.41M |
| Enterprise Value | 326.62M |
| Gross Profit Margin (Quarterly) | 64.52% |
| Profit Margin (Quarterly) | 13.47% |
| Earnings Yield | 5.01% |
| Operating Earnings Yield | 4.70% |
| Normalized Earnings Yield | 5.008 |